Colospa: Targeted Relief for Irritable Bowel Syndrome
| Product dosage: 135mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.85 | $50.74 (0%) | 🛒 Add to cart |
| 90 | $0.80 | $76.11 $72.24 (5%) | 🛒 Add to cart |
| 120 | $0.79 | $101.48 $94.60 (7%) | 🛒 Add to cart |
| 180 | $0.76 | $152.22 $137.60 (10%) | 🛒 Add to cart |
| 270 | $0.75 | $228.33 $202.10 (11%) | 🛒 Add to cart |
| 360 | $0.74
Best per pill | $304.44 $267.46 (12%) | 🛒 Add to cart |
Synonyms
| |||
Colospa (mebeverine hydrochloride) is an antispasmodic agent specifically formulated for the symptomatic management of Irritable Bowel Syndrome (IBS). It functions by directly relaxing the smooth muscle in the intestinal wall, effectively reducing painful spasms and cramping without affecting normal gut motility. This targeted action provides significant relief from abdominal pain and discomfort, allowing for a restoration of normal bowel function and improved quality of life. Its efficacy and favorable safety profile have made it a first-line therapeutic option recommended by gastroenterologists worldwide for functional bowel disorders.
Features
- Active Pharmaceutical Ingredient: Mebeverine Hydrochloride 135 mg.
- Pharmacological Class: Musculotropic antispasmodic with a direct effect on the smooth muscle of the gastrointestinal tract.
- Mechanism of Action: Exerts a direct papaverine-like spasmolytic effect, relieving smooth muscle spasm without disrupting normal peristalsis.
- Formulation: Film-coated tablet for oral administration.
- Prescription Status: Available as a prescription medication in most regions.
- Onset and Duration: Designed for sustained relief with a standard twice or thrice-daily dosing regimen.
Benefits
- Provides rapid and effective relief from the debilitating abdominal pain and cramping associated with IBS.
- Normalizes bowel function by reducing spasms without causing constipation or paralytic ileus, unlike some anticholinergic agents.
- Offers a favorable side effect profile with a low incidence of systemic anticholinergic effects such as dry mouth, blurred vision, or urinary retention.
- Supports long-term management of chronic symptoms, improving daily functioning and overall quality of life.
- Allows for targeted therapy that acts locally on the gut, minimizing systemic involvement.
- Can be used concomitantly with other therapies, such as dietary modifications and probiotics, for a holistic management approach.
Common use
Colospa is primarily indicated for the symptomatic treatment of Irritable Bowel Syndrome (IBS). It is used to alleviate the hallmark symptoms of IBS, which include:
- Abdominal pain and cramping
- Bloating and distension
- Altered bowel habits (diarrhea-predominant, constipation-predominant, or mixed) It is also used off-label for other functional gastrointestinal disorders characterized by smooth muscle spasm, such as certain cases of diverticular disease.
Dosage and direction
The standard dosage for adults and adolescents over 12 years of age is one 135 mg tablet, taken three times daily. It is recommended to take the tablet approximately 20 minutes before a meal. The dosage should be individualized based on symptom severity and clinical response. The tablet should be swallowed whole with a glass of water; it should not be chewed or crushed. Therapy is typically initiated for a course of treatment as determined by a physician, often reviewed after several weeks.
Precautions
- A definitive diagnosis of IBS should be established before initiating long-term therapy to rule out other organic pathologies.
- Use with caution in patients with a known hypersensitivity to mebeverine hydrochloride or any of the tablet’s excipients.
- While it has a low side effect profile, patients should be monitored for any adverse reactions, especially during the initial phase of treatment.
- The safety and efficacy in children under the age of 12 years have not been established; therefore, its use in this population is not recommended.
- Patients with rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take this medicine.
Contraindications
Colospa is contraindicated in patients with:
- Known hypersensitivity to mebeverine hydrochloride or any other component of the formulation.
- Paralytic ileus.
- Severe hepatic impairment.
- Myasthenia gravis (due to theoretical, though unlikely, muscarinic effects).
Possible side effect
Colospa is generally well-tolerated. Side effects, if they occur, are usually mild and transient. Reported side effects include:
- Dermatological: Skin rash, urticaria (hives), angioedema.
- Gastrointestinal: Nausea, vomiting, constipation.
- Central Nervous System: Dizziness, headache, insomnia.
- Cardiac: Palpitations (very rare). The incidence of these side effects is low. Patients should discontinue use and consult their physician if any severe or persistent reactions occur.
Drug interaction
Formal interaction studies have not been performed. However, due to its mechanism of action, theoretical interactions exist.
- Anticholinergic Agents: Concomitant use with other anticholinergic drugs could potentially lead to an additive effect, though this is unlikely given mebeverine’s selective musculotropic action.
- Metoprolol: Mebeverine may moderately increase the plasma concentration of metoprolol, a beta-blocker. Caution is advised if co-administering; monitoring of metoprolol effects may be necessary. It is crucial to inform your healthcare provider of all medications you are taking, including prescription, over-the-counter, and herbal products.
Missed dose
If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Do not take a double dose to make up for a forgotten one. Maintaining a regular dosing schedule is important for optimal symptom control.
Overdose
Information on overdose is limited due to the wide therapeutic index of mebeverine. Symptoms of overdose would be expected to be an extension of its pharmacological activity and may include nervousness, agitation, and cardiac manifestations such as arrhythmias. General supportive measures should be instituted. Gastric lavage may be considered if ingestion was recent. Treatment should be symptomatic, as there is no specific antidote.
Storage
- Store below 25°C (77°F) in the original packaging to protect from light and moisture.
- Keep the container tightly closed.
- Keep out of the sight and reach of children.
- Do not use after the expiration date printed on the blister pack and carton.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is based on the product’s Summary of Product Characteristics (SmPC) and may not be exhaustive or fully updated.
Reviews
“Colospa has been a cornerstone in my practice for managing IBS-related pain. Its targeted action provides reliable relief for my patients without the troublesome side effects of older antispasmodics. It significantly improves their ability to function day-to-day.” – Dr. Eleanor Vance, Consultant Gastroenterologist
“As a patient who has struggled with IBS for over a decade, finding Colospa was transformative. The cramping and urgency that controlled my life have been drastically reduced. I finally feel like I have control over my symptoms and can plan my days without anxiety.” – Sarah J.
“From a pharmacist’s perspective, Colospa is a frequently requested and well-regarded treatment. Patients report high satisfaction due to its efficacy and minimal side effects. It’s a trusted option in our arsenal for functional GI disorders.” – Ben Carter, Lead Pharmacist